Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China · Delayed Price · Currency is CNY 83.06
-0.69 (-0.82%)
Jun 17, 2026, 3:00 PM CST
SHA:688578 Revenue
Shanghai Allist Pharmaceuticals had revenue of 1.58B CNY in the quarter ending March 31, 2026, with 44.19% growth. This brings the company's revenue in the last twelve months to 5.67B, up 44.95% year-over-year. In the year 2025, Shanghai Allist Pharmaceuticals had annual revenue of 5.19B with 45.80% growth.
Revenue (ttm)
5.67B
Revenue Growth
+44.95%
P/S Ratio
6.64
Revenue / Employee
2.85M
Employees
1,989
Market Cap
37.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.19B | 1.63B | 45.80% |
| Dec 31, 2024 | 3.56B | 1.54B | 76.29% |
| Dec 31, 2023 | 2.02B | 1.23B | 155.14% |
| Dec 31, 2022 | 791.00M | 260.91M | 49.22% |
| Dec 31, 2021 | 530.09M | 529.53M | 94,409.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Revenue RankingsShanghai Allist Pharmaceuticals News
- 2 months ago - Shanghai Allist Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 2 months ago - Shanghai Allist Pharmaceuticals Annual report: Q4 2025 - Filings
- 8 months ago - Shanghai Allist Pharmaceuticals Quarterly report: Q3 2025 - Filings
- 10 months ago - Shanghai Allist Pharmaceuticals Quarterly report: Q2 2025 - Filings